Demystifying Employer Collaborations-Pharma/Biotech
Employers as plan sponsors or purchasers of healthcare represent approximately 60% of the commercial insurance market dollars, and thus represent a large opportunity for healthcare, life science, medical device and pharmaceutical companies.
There has been greater interest in the Employer market as direct contracting has emerged for those who offer specialized services or other unique products for those covered by health insurance programs.
The self-insured employer-sponsored health plan market has seen rapid growth since ACA implementation, to over 95,000 companies. Eighty percent of U.S. employers have less than 2,000 employees as members of the plan. With less than 2,000 employees, these companies would be considered to be small to medium sized employers who are self-funding or holding the financial risk in offering health benefits to their employees.
Fortune 500 employers represent a very small fraction of all employers comprising fewer than one one-hundredth of 1% of employers, but making up more than 8% of all employees. Fortune 500 employers have a disproportionate impact on healthcare policy and attention in the market.
This Insight report reviews and identifies key benefit design trends discussed in recent Access Market Intelligence webinars or written reports, and describes the impact Employer trends will have on the pharmaceutical and medical device industry for 2017 and beyond. Table of Contents
- Introduction – pg. 4
- Employer Market Segment: SIZE and SCOPE – pg. 4
- Types of Employers – pg. 6
- Pharmaceutical-based Benefits and Coverage Trends – pg. 10
- Business on Health Coalitions – pg. 11
- Employers’ Benefit Design Decision Basics and Key Timelines – pg. 13
- Sales Planning – pg. 15
- Best Practices in the Employer Segment – pg. 17
- Summary of Key Points – pg. 19